-
REGN Dashboard
- Financials
- Filings
- Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Regeneron Pharmaceuticals (REGN)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.49 bn | 2.49 bn | 2.49 bn | 2.49 bn | 2.49 bn | 2.49 bn |
Cash burn (monthly) | (no burn) | 20.73 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 43.82 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 2.45 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 117.9 | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 1271 |
Opened positions | 156 |
Closed positions | 245 |
Increased positions | 465 |
Reduced positions | 476 |
13F shares | Current |
---|---|
Total value | 61.64 tn |
Total shares | 92.72 mm |
Total puts | 1.37 mm |
Total calls | 1.52 mm |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 9.29 mm | $6.61 tn |
BlackRock | 8.73 mm | $6.22 tn |
FMR | 8.20 mm | $5.84 tn |
JPM JPMorgan Chase & Co. | 7.06 mm | $5.03 tn |
STT State Street | 4.83 mm | $3.44 tn |
Capital International Investors | 4.74 mm | $3.37 tn |
Capital World Investors | 2.78 mm | $1.98 tn |
Geode Capital Management | 2.43 mm | $1.73 tn |
Dodge & Cox | 2.32 mm | $1.65 tn |
T. Rowe Price | 2.09 mm | $1.49 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Bassler Bonnie L | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,548 |
2 Jan 25 | Bassler Bonnie L | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Kathryn Guarini | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 448 |
2 Jan 25 | Kathryn Guarini | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Ryan Arthur F | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 17,748 |
2 Jan 25 | Ryan Arthur F | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Zoghbi Huda Y | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,548 |
2 Jan 25 | Zoghbi Huda Y | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Goldstein Joseph L | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 6,548 |
2 Jan 25 | Goldstein Joseph L | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |